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Erratum
MLH1 mediates PARP-dependent cell death in response to the
methylating agent N-methyl-N-nitrosourea
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Correction to: British Journal of Cancer (2009) 101, 441–451;
doi:10.1038/sj.bjc.6605186
Owing to an error during the final correction of this paper,
panels E and F in Figure 4 were incorrectly typeset, resulting
in the loss of part of panel 4E. The publishers apologise for this
mistake.
The correct panels 4E and 4F are reproduced below:
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Figure 4 Differences in PARP activity and in viability between WT and MLH1-depleted cells. (E) WT and M1 cells were treated with 2mM MNU, either
alone or in combination with 30mM DPQ or 10mM Boc-D-FMK; as a control, cells treated with camptothecin were assayed at 72h; values represent the
mean of three samples ±s.d.; ***Po0.001; *Po0.05; NS, not significant. (F) Clonogenic assays in response to 2mM MNU, 30mM DPQ or a combination of
the two were carried out on the indicated cell lines with two plates per cell line; error bars indicate ±s.d. values. The assay was carried out three times for
the fibroblasts (WT and M1), with representative results shown, and once for the controls (HCT116 and HCT116þchr3).
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